Ongoing management of bipolar disorder

Author/s
Snehal Khajuria
Citation
Issue 3 Summer 2013
CEPiP.2013;1:220-223
Abstract

Bipolar (affective) disorder is a challenging psychiatric illness to manage and is associated with significant risk of morbidity and mortality. A meta-analysis has revealed that suicide is 20 times higher in patients with bipolar than the general population (7). Acute relapses of bipolar are often managed in secondary care with hospitalisation whereas long-term maintenance management is achieved largely in primary care. This paper discusses the ways in which lifestyle, psychotherapy and pharmacotherapy can be utilised in maintenance management, how they are advantageous in patients and what obstacles are faced.

Keywords: bipolar disorder, maintenance management, pharmacotherapy, psychotherapy, lifestyle management, non-compliance, monitoring bipolar, primary care

Cite as: Cutting Edge Psychiatry in Practice 2013, 3(1):220-223; https://doi.org/10.65031/rmiq4342

References

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders 1994.         
  2. Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry2011;68:1058-64 https://doi.org/10.1001/archgenpsychiatry.2011.113
  3. Morselli PL, Elgie R; GAMIAN-Europe. GAMIAN-Europe/BEAM survey I--global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord. 2003 Aug;5 (4):265-78. https://doi.org/10.1034/j.1399-5618.2003.00037.x
  4. Vazquez-Barquero JL, Artal J, Caballero-Martinez P. FC3A Early Intervention In Bipolar Disorders: Rationale for the overdue implementation of a Feasible Paradigm. Schizophrenia Research 2006;86;S3-S37. https://doi.org/10.1016/s0920-9964(06)70109-8
  5. NICE guidelines: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care CG38 (2003)
  6. Parikh SV, LeBlanc SR, Ovanessian MM. Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Can J Psychiatry. 2010;55 (3):136-143 https://doi.org/10.1177/070674371005500304
  7. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 2010;12 (1):1-9. https://doi.org/10.1111/j.1399-5618.2009.00786.x
  8. Ostacher MJ, Lebeau RT, Perlis RH, et al. Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord. 2009;11 (7):766-771. https://doi.org/10.1111/j.1399-5618.2009.00744.x
  9. Price AL, Marzani-Nizzen GR. Bipolar Disorders: A Review. American Family Physician; 2012; 85 (5):483-493       
  10. Gardner DM, Murphy AL, O’Donnell H, et al. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167 (6):686-693.          
  11. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152 (11):1635-1640.  
  12. Altshuler LL, Post RM, Leverich GS et al. Antidepressant-induced manic and cyclic acceleration : a controversy revisited. Am J Psychiatry 1995; 152: 1130- 1138 https://doi.org/10.1176/ajp.152.8.1130
  13. Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5: 407-420 https://doi.org/10.1046/j.1399-5618.2003.00067.x
  14. Suppes T, Kelly DI, Perla JM. Challenges in the Management of Bipolar Depression. J Clin Psychiatry 2005; 66 (suppl 5) 11- 16               
  15. Baldessarini RJ Tondo L, Hennen J et al. Is lithium still worth using ? an update of selected recent research. Harv Rev Psychiatry 2002; 10: 59-75 https://doi.org/10.1080/hrp.10.2.59.75
  16. Thase ME Sachs GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry 2000; 48: 558-572 https://doi.org/10.1016/s0006-3223(00)00980-x
  17. Ghaemi SN, Sachs GS, Goodwin FK. What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness. World J Biol Psychiatry 2000: 1; 65-74 https://doi.org/10.3109/15622970009150569
  18. Grunze H. Re-evaluating therapies for bipolar depression. J Clin Psychiatry 2005; 66 (suppl 5) : 17-25
  19. Yatham LN, Kennedy SH, Schaffer A, et al.; Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11 (3):225-255. https://doi.org/10.1111/j.1399-5618.2009.00672.x
  20. Burgess S, Geddes J, Hawton K, et al. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. 2001; (3):CD003013. https://doi.org/10.1002/14651858.cd003013
  21. Cipriani A, Rendell JM, Geddes J. Olanzapine in long-term treatment for bipolar disorder. Cochrane Database Syst Rev. 2009; (1):CD004367. https://doi.org/10.1002/14651858.cd004367
  22. Sajatovic M, Valenstein M, Blow F et al. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 2007;58:855-63. https://doi.org/10.1176/ps.2007.58.6.855
  23. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56 (5):407-412. https://doi.org/10.1001/archpsyc.56.5.407
  24. Milano W, Grillo F, Del Mastro A, et al. Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study. Adv Ther. 2007;24 (1):123-134. https://doi.org/10.1007/bf02850000
  25. Anderson IM, Haddad PM, Scott J. Bipolar Disorder. BMJ Jan 2013 (346): 27-32                 
  26. Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13 (1):87-98. https://doi.org/10.1111/j.1399-5618.2011.00889.x
  27. Castle D, White C, Chamberlain J, et al. Group-based psychosocial intervention for bipolar disorder: randomised controlled trial. Br J Psychiatry. 2010;196 (5):383-388. https://doi.org/10.1192/bjp.bp.108.058263
  28. Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry. 2008;165 (11):1408-1419. https://doi.org/10.1176/appi.ajp.2008.08040488
  29. Judd LL, Akiskal HS, Schettler PJ et al: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530–537 https://doi.org/10.1001/archpsyc.59.6.530
  30. Colom F, Vieta E, Tacchi MJ et al.: Identifying and improving non-adherence in bipolar disorders. Bipolar Disord 2005; 7:24–31
  31. Sullivan AE, Miklowitz DJ. Family functioning among adolescents with bipolar disorder. J Fam Psychol. 2010;24 (1):60-67.   
  32. Morriss RK, Faizal MA, Jones AP et al. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev. 2007; (1):CD004854. https://doi.org/10.1002/14651858.cd004854
  33. Cassidy F. Risk factors of attempted suicide in bipolar disorder. Suicide Life Threat Behav. 2011;41(1):6-11. https://doi.org/10.1111/j.1943-278x.2010.00007.x
  34. Fiedorowicz JG, Solomon DA, Endicott J, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med. 2009;71 (6):598-606. https://doi.org/10.1097/psy.0b013e3181acee26
  35. Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand. 2009 March;119 (3):171-9 https://doi.org/10.1111/j.1600-0447.2008.01334.x